Jiuzhou Pharmaceutical(SH:603456) Xin Lang Cai Jing·2025-10-14 02:10Group 1 - The core viewpoint of the news is that Jiuzhou Pharmaceutical experienced a stock price increase of 5.28%, reaching 20.32 CNY per share, with a total market capitalization of 18.074 billion CNY [1] - Jiuzhou Pharmaceutical, established on July 13, 1998, and listed on October 10, 2014, specializes in the research, production, and sales of chemical raw materials and pharmaceutical intermediates [1] - The company's main business revenue composition includes 79.81% from new drug custom development and production services (CDMO), 18.22% from specialty raw materials and intermediates, and 1.96% from other sources [1] Group 2 - New沃 Fund has a significant holding in Jiuzhou Pharmaceutical, with the New沃 Tongying Flexible Allocation Mixed Fund (002564) holding 15,900 shares, accounting for 3.56% of the fund's net value, ranking as the tenth largest holding [2] - The New沃 Tongying Flexible Allocation Mixed Fund was established on September 22, 2016, with a latest scale of 6.8023 million CNY, and has achieved a year-to-date return of 9.96% [2] - The fund's performance over the past year shows a return of 12.66%, ranking 5,474 out of 8,015 in its category, and a cumulative return of 92.14% since inception [2]